AJR ARRS Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gross, C. M.
Right arrow Articles by Dietz, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gross, C. M.
Right arrow Articles by Dietz, R.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

American Journal of Roentgenology, Vol 169, 429-432, Copyright © 1997 by American Roentgen Ray Society

ARTICLES

Stent implantation in patients with superior vena cava syndrome

CM Gross, J Kramer, J Waigand, F Uhlich, G Schroder, C Thalhammer, R Dechend, DC Gulba and R Dietz
Department of Cardiology, Angiology and Pulmology, Franz Volhard Clinic at the Max Delbruck Center for Molecular Medicine, Humboldt University, Berlin, Germany.

OBJECTIVE: The purpose of this study was to determine the feasibility of using Wallstent implantation to treat superior vena cava syndrome due to malignant tumors. SUBJECTS AND METHODS: Digital subtraction angiography showed obstruction of the superior vena cava in 13 patients who then underwent transluminal dilatation and Wallstent implantation. The patients were treated with IV heparin and monitored in the emergency department. Thereafter, they were treated with a platelet inhibitor for 4 weeks. RESULTS: Because their signs and symptoms improved, patients were able to resume radiation therapy, chemotherapy, or both. One patient died of cardiac arrhythmia 1 day after stent placement. Although eight patients have subsequently died of their bronchial or thyroid gland tumors, superior vena cava syndrome did not recur in any patient. CONCLUSION: Percutaneous implantation of Wallstent endoprostheses provides excellent palliation for superior vena cava syndrome.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
P. Courtheoux, B. Alkofer, M. Al Refai, R. Gervais, J. P. Le Rochais, and P. Icard
Stent placement in superior vena cava syndrome
Ann. Thorac. Surg., January 1, 2003; 75(1): 158 - 161.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
C. Lanciego, J. L. Chacon, A. Julian, J. Andrade, L. Lopez, B. Martinez, M. Cruz, and L. Garcia-Garcia
Stenting as First Option for Endovascular Treatment of Malignant Superior Vena Cava Syndrome
Am. J. Roentgenol., September 1, 2001; 177(3): 585 - 593.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
M Peters, S V Beath, J W L Puntis, and P John
Superior vena cava thrombosis causing respiratory obstruction successfully resolved by stenting in a small bowel transplant candidate
Arch. Dis. Child., August 1, 2000; 83(2): 163 - 164.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
M. K. Razavi, E. C. Hansch, S. T. Kee, D. Y. Sze, C. P. Semba, and M. D. Dake
Chronically Occluded Inferior Venae Cavae: Endovascular Treatment1
Radiology, January 1, 2000; 214(1): 133 - 138.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Roentgen Ray Society.